Naujienos
- Latest Research Evaluating VASCEPA® (Icosapent Ethyl) to be Presented at the American College of Cardiology’s 71st Annual Scientific Session
21.03.2022 / 13:30 - GlobeNewswire
-
- Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Clariant, and Anavex and Encourages Investors to Contact the Firm
21.03.2022 / 02:00 - GlobeNewswire
-
- Centerra Gold Announces Temporary Suspension of Gold Doré Bar Production at the Öksüt Mine
18.03.2022 / 12:16 - GlobeNewswire
-
- Bragar Eagel & Squire, P.C. Is Investigating Medallion, Clariant, Anavex, and Embark and Encourages Investors to Contact the Firm
15.03.2022 / 02:38 - GlobeNewswire
-
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DiDi Global Inc. - DIDI
14.03.2022 / 23:31 - GlobeNewswire
-
- Park Hotels & Resorts Reinstates Dividend and Provides Brief Update on Operating Trends
11.03.2022 / 12:00 - GlobeNewswire
-
- Latest analysis shows VASCEPA® (icosapent ethyl) significantly lowered the risk of potentially fatal cardiovascular events in patients with prior percutaneous coronary intervention
10.03.2022 / 14:47 - GlobeNewswire
-
- Bragar Eagel & Squire, P.C. Is Investigating Corcept, Medallion, Clariant, and Anavex and Encourages Investors to Contact the Firm
10.03.2022 / 03:00 - GlobeNewswire
-
- Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Corcept, and Clariant and Encourages Investors to Contact the Firm
05.03.2022 / 03:00 - GlobeNewswire
-
- CLARIANT AG INVESTOR ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Clariant AG To Contact Him Directly To Discuss Their Options
27.02.2022 / 14:18 - GlobeNewswire